Morgan Stanley Tactical Value Provides Up to $150MM Non-Dilutive Term Loan to Fibrogen
FibroGen entered into a non-dilutive term loan facility with investment funds managed by Morgan Stanley Tactical Value that will result in proceeds to FibroGen of up to $150 million, providing non-dilutive capital to support growth and innovation.